Spierrelaxantia en antagonisten
Publisher
Bohn Stafleu van Loghum
Reference7 articles.
1. Brull SJ, Murphy GS. Residual neuromuscular block: lessons unlearned. Part II: methods to reduce the risk of residual weakness. Anesth Analg. 2010;111:129–40.
2. Evers AS, Maze M, Kharasch ED. Anesthetic pharmacology. 2nd ed. Cambridge: Cambridge University Press; 2011.
3. Kopman AF, Naguib M. Laparoscopic surgery and muscle relaxants: is deep block helpful? Anesth Analg. 2015;120:51–8.
4. McLean DJ, Diaz-Gil D, Farhan HN, Ladha KS, Kurth T, Eikermann M. Dose-dependent association between intermediate-acting neuromuscular-blocking agents and postoperative respiratory complications. Anesthesiology 2015;122:1201–13 (CME credits).
5. Sparr HJ, Beaufort TM, Fuchs-Buder T. Newer neuromuscular blocking agents: how do they compare with established agents? Drugs 2001;61:919–42.